NW Bio commences Phase III trial of DCVax-L for brain cancer
Northwest Biotherapeutics (NW Bio) has announced the commencement of a...
Novo Nordisk announces positive results from phase 3 haemophilia B trial
Novo Nordisk has announced positive results from phase 3 trial...
Trillium completes dosing in Phase I cystitis/bladder pain syndrome study of TTI-1612
Trillium Therapeutics, a wholly-owned subsidiary of Stem Cell...
FDA approves Xofigo prostate cancer drug
The USFDA has approved Xofigo (radium Ra 223 dichloride) for the treatment...
Soligenix commences Phase I paediatric Crohn's disease study of SGX203
Clinical-stage biopharmaceutical company Soligenix has initiated a Phase...
See all news
Proven Autoclave Design a Long Runner
Friday, May 17, 2013
by Priorclave
Top-loading laboratory autoclaves are the longest serving stalwarts of...
Bachem Adds 11 New Research Products to Online Catalogue
Friday, May 17, 2013
by Bachem
Bachem is continuously expanding and updating its extensive range...
Meet Biovian at BioTrinity 2013 - European Biopartnering and Investment Conference - 14-16 May 2013, Newbury, UK
Wednesday, May 15, 2013
by Biovian
Meet Biovian at BioTrinity 2013 - European Biopartnering and...
New Mammalian cGMP Cell Banking Facility Commissioned by Fujifilm Diosynth Biotechnologies
Tuesday, April 30, 2013
by Fujifilm Diosynth Biotechnologies
Fujifilm Diosynth Biotechnologies has announced that it has commissioned...
Tissue Solutions to Exhibit at 2013 BIO International Convention, Booth 4438, Apr 22 - 25, 2013, in Chicago IL, US
Monday, April 22, 2013
by Tissue Solutions
Tissue Solution invites pharmaceutical and biotech companies to visit...
See all press releases
Twitter
Facebook